previous compound ID: 2325 next compound
InChIKey: VGZSUPCWNCWDAN-UHFFFAOYSA-N
SMILES: CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"B Kus" "DY Thomas" "GW Carlile" "D Rotin" "SD Macknight" "E Matthes" "JW Hanrahan" "J Liao" "J Goepp" "R Robert"

chemical graph of compound 2325





CID is 1989
synonyms found at PubChem are:
acetohexamide, 968-81-0, Dymelor, Acetohexamid, Gamadiabet, Dimelor, Hypoglicil, Metaglucina, Tsiklamid, Dimelin, Minoral, Ordimel, Acetohexamida, Acetohexamidum, N-(p-Acetylphenylsulfonyl)-N'-cyclohexylurea, Acetohexamidum [INN-Latin], Acetohexamida [INN-Spanish], 1-((p-Acetylphenyl)sulfonyl)-3-cyclohexylurea, ord imel, CCRIS 4, NCI-C03247, UNII-QGC8W08I6I, 1-(4-acetylphenyl)sulfonyl-3-cyclohexylurea, 1-(p-Acetylbenzenesulfonyl)-3-cyclohexylurea, Dymelor (TN), U-14812, dimelin (antidiabetic), HSDB 3280, 4-Acetyl-N-((cyclohexylamino)carbonyl)benzenesulfonamide, 4-Acetyl-N-[(cyclohexylamino)carbonyl]benzenesulfonamide, Benzenesulfonamide, 4-acetyl-N-[(cyclohexylamino)carbonyl]-, Acetohexamide [USAN:INN:BAN:JAN], EINECS 213-530-4, U 14812, BRN 2225115, QGC8W08I6I, Benzenesulfonamide, 4-acetyl-N-((cyclohexylamino)carbonyl)-, 3-(4-acetylbenzenesulfonyl)-1-cyclohexylurea, C15H20N2O4S, CHEBI:28052, N-(p-Acetylbenzenesulfonyl)-N'-cyclohexylurea, 4-Acetyl-N-[(cyclohexylamino)-carbonyl]benzenesulfonamide, DSSTox_CID_7, NCGC00015014-05, CAS-968-81-0, 3-cyclohexyl-1-(p-acetylphenylsulfonyl)urea, A-178, 1-[(p-Acetylphenyl)sulfonyl]-3-cyclohexylurea, DSSTox_RID_75319, 4-acetyl-N-(cyclohexylcarbamoyl)benzenesulfonamide, DSSTox_GSID_20007, Urea, 1-((p-acetylphenyl)sulfonyl)-3-cyclohexyl-, Urea, 1-[(p-acetylphenyl)sulfonyl]-3-cyclohexyl-, 4-acetyl-N-((cyclohexylamino)carbonyl)benzenesulf onamide, SR-01000075539, Prestwick_3, Acetohexamide [USAN), Acetohexamide [USAN:USP:INN:BAN:JAN], Lopac-A-178, AC1L1COE, Acetohexamide Lilly Brand, Prestwick0_000055, Prestwick1_000055, Prestwick2_000055, Prestwick3_000055, Acetohexamide Salvat Brand, D07WFK, CHEMBL1589, Lilly Brand of Acetohexamide, Lopac0_000088, SCHEMBL37620, BSPBio_000209, MLS002154186, Salvat Brand of Acetohexamide, SPBio_002130, BPBio1_000231, GTPL6793, DTXSID7020007, CTK8F7520, Acetohexamide (JP15/USP/INN), Acetohexamide (JP17/USP/INN), Acetohexamide, analytical standard, MolPort-003-666-680, VGZSUPCWNCWDAN-UHFFFAOYSA-N, HMS1568K11, HMS2093H21, HMS2095K11, HMS2236M07, HMS3260A18, HMS3372B02, HMS3712K11, Pharmakon1600-01505425, HY-B0881, KS-00001F9N, Tox21_110067, Tox21_202022, Tox21_302735, Tox21_500088, MFCD00072156, NSC759128, ZINC18067894, AKOS015916290, Tox21_110067_1, API0002381, CCG-204183, DB00414, LP00088, LS-2019, MCULE-3744173137, NSC-759128, VZ31185, NCGC00015014-01, NCGC00015014-02, NCGC00015014-03, NCGC00015014-04, NCGC00015014-06, NCGC00015014-07, NCGC00015014-08, NCGC00015014-11, NCGC00016555-01, NCGC00091230-01, NCGC00091230-02, NCGC00091230-03, NCGC00091230-04, NCGC00256467-01, NCGC00259571-01, NCGC00260773-01, CC-23668, SC-70790, SMR001233477, SBI-0050076.P002, EU-0100088, FT-0661053, 1-(4-acetylbenzenesulfonyl)-3-cyclohexylurea, 1-(4-acetylphenyl)sulfonyl-3-cyclohexyl-urea, 1-cyclohexyl-3-(4-ethanoylphenyl)sulfonyl-urea, C06806, D00219, 1-[(4-acetylbenzene)sulfonyl]-3-cyclohexylurea, A845651, C-19808, SR-01000075539-1, SR-01000075539-3, SR-01000075539-6, 4-acetyl-N-(cyclohexylcarbamoyl)benzene-1-sulfonamide, BRD-K52960356-001-03-1, BRD-K52960356-001-06-4, I14-51513, Z1558572527, 4-Acetyl-N-[(cyclohexylamino)- carbonyl]benzenesulfonamide, 1-Acetyl-4-(([(cyclohexylamino)carbonyl]amino)sulfonyl)benzene #, Acetohexamide, United States Pharmacopeia (USP) Reference Standard, 1-[(4-acetylbenzene)sulfonyl]-3-cyclohexylurea 4-acetyl-N-(cyclohexylcarbamoyl)benzenesulfonamide, 8054-32-8